Study S001277

The Effect of Adherence to Oral Semaglutide on Glycaemic Control in People With Type 2 Diabetes Treated With Metformin (DIACRON) - An Open-label Clinical Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06333080
Acronym: DIACRON
Study type: OBSERVATIONAL
Status: TERMINATED
Enrollment: 1
Start: 2023-11-01
Primary completion: 2025-07-29
Lead sponsor: Aalborg University Hospital
Conditions: Diabetes Mellitus, Type 2
Results posted: FALSE

Registered primary outcomes

Time-in-Range (TIR) [Change from baseline to three-month assessment]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0006479	Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial. Holdt-Caspersen NS, JMIR research protocols	2025	Protocol	PMID 40986866 DOI	cites ClinicalTrials.gov:NCT06333080; registry reference DERIVED:40986866
R0038009	Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial (Preprint) Nynne Sophie Holdt-Caspersen	2024	Protocol	DOI	cites ClinicalTrials.gov:NCT06333080